There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Structure of Sunitinib
CAS No.: 557795-19-4
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50 values of 80 nM for VEGFR2 and 2 nM for PDGFRβ. As an ATP-competitive inhibitor, Sunitinib effectively inhibits autophosphorylation of Ire1α, thereby preventing RNase activation.
Synonyms: SU 11248
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Marlhoux, Léna ; Arnaud, Alexandre ; Hervieu, Céline ; Makulyte, Gabriela ; Martinasso, Charlotte ; Mularoni, Angélique , et al.
Abstract: Casein kinase 2 (CK2) has emerged as a promising therapeutic target across a broad spectrum of malignancies, including pediatric and orphan cancers. The identification of a ligandable allosteric αD pocket on the CK2α subunit has enabled the development of bivalent inhibitors, which bind simultaneously to both the adenosine triphosphate (ATP) site and the allosteric pocket. Here, we report the discovery and pharmacological characterization of KDX1381, a structure-guided bivalent CK2α inhibitor with low-nanomolar potency and high selectivity, confirmed by cocrystal structures. In mice, KDX1381 suppressed CK2-driven tumor growth as a monotherapy and enhanced therapeutic efficacy when combined with vascular endothelial growth factor receptor (VEGFR) inhibitors or DNA-damaging agents in hepatocellular carcinoma and glioma models. These findings support bivalent CK2α inhibition as a differentiated therapeutic strategy with broad applicability in CK2-dependent cancers.
Show More >
Purchased from AmBeed: 61825-94-3 ; 1009820-21-6 ; 444731-52-6 ; 85622-93-1 ; 557795-19-4 ; 755037-03-7 ; 849217-68-1 ; 15663-27-1 ; 284461-73-0 ; 417716-92-8 ; 51-21-8
Show More >
CAS No. : | 557795-19-4 |
Formula : | C22H27FN4O2 |
M.W : | 398.47 |
SMILES Code : | CCN(CCNC(C(C(C)=C1/C([H])=C(C2=O)/C3=C(N2)C=CC(F)=C3)=C(N1)C)=O)CC |
Synonyms : |
SU 11248
|
MDL No. : | MFCD09260778 |
InChI Key : | WINHZLLDWRZWRT-ATVHPVEESA-N |
Pubchem ID : | 5329102 |
GHS Pictogram: |
![]() |
Signal Word: | Danger |
Hazard Statements: | H360-H372 |
Precautionary Statements: | P201-P202-P260-P264-P270-P280-P308+P313-P405-P501 |
Class: | 6.1 |
UN#: | 2811 |
Packing Group: | Ⅲ |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
CD8+ T cells | 2.5 μM | overnight | Sunitinib inhibits Stat3 activity in CD8+ T cells | PMC3017475 |
HMLER-FOXC2 cells | 10 µM | 7 days | To test the effect of Sunitinib on mammosphere formation in HMLER-FOXC2 cells, results showed that Sunitinib significantly reduced mammosphere formation. | PMC3602160 |
HMLER-Snail cells | 10 µM | 7 days | To test the effect of Sunitinib on mammosphere formation in HMLER-Snail cells, results showed that Sunitinib significantly reduced mammosphere formation. | PMC3602160 |
Human umbilical vein endothelial cells (HUVECs) | 1 nM | 9 days | To evaluate the effect of Sunitinib on IL-36 or VEGF-A stimulated HUVECs angiogenesis, results showed that Sunitinib significantly inhibited IL-36 and VEGF-A induced angiogenesis | PMC5834930 |
786-0 cells | 2μM to 5μM | Establishment of sunitinib-resistant cell line 786-0R and evaluation of its resistance to sunitinib. | PMC4326587 | |
786-0shRNA and 786-0shEZH2 cells | 2μM, 4μM, 6μM, 8μM | 48 h | Evaluation of the effect of EZH2 knockdown on sunitinib sensitivity, results showed increased sensitivity to sunitinib after EZH2 knockdown. | PMC4326587 |
786-O cells | 100 μM | 24 h | To validate the impact of AA on Sunitinib's inhibition of ccRCC cell proliferation and invasion, results showed that AA enhanced the inhibitory effect of Sunitinib. | PMC10352361 |
ACHN cells | 100 μM | 24 h | To validate the impact of AA on Sunitinib's inhibition of ccRCC cell proliferation and invasion, results showed that AA enhanced the inhibitory effect of Sunitinib. | PMC10352361 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
C.B17/Icr-scid mice | PNX0010 xenograft tumour model | oral | 40 mg/kg | 5 days per week | To examine the effect of a high-fat/high-cholesterol diet on the antitumour efficacy of Sunitinib, and found that the high-fat/high-cholesterol diet diminished the antitumour effect of Sunitinib | PMC5418451 |
mice | Renca renal cell carcinoma model | oral | 30-40 mg/kg | once daily for up to 14 days | Sunitinib combined with CD8+ T cell adoptive transfer significantly inhibited tumor growth and inhibited Stat3 activity | PMC3017475 |
NOD/SCID mice | HMLER-FOXC2 tumor model | oral | 40 mg/kg | 5 days a week for 30 days | To evaluate the effect of Sunitinib on HMLER-FOXC2 tumor growth and animal survival, results showed that Sunitinib significantly reduced tumor growth and extended event-free survival. | PMC3602160 |
mice | nude mice | gavage feeding | 40 mg/kg/mouse | five times a week | Establishment of sunitinib-resistant renal cell carcinoma cell lines | PMC7226215 |
Mice | RP-R-01 and RP-R-02 patient-derived ccRCC xenograft models | Oral gavage | 40 mg/kg | 5 days/week, until tumor resistance | Evaluation of the effect of sunitinib dose escalation on overcoming resistance in ccRCC xenograft models, results showed that dose escalation restored tumor sensitivity to sunitinib. | PMC4326587 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00372775 | Non-Small Cell Lung Cancer | PHASE2 | COMPLETED | 2025-12-09 | Pfizer Investigational Site, N... More >>orwalk, Connecticut, 06856, United States|Pfizer Investigational Site, Cocoa Beach, Florida, 32931, United States|Pfizer Investigational Site, Merritt Island, Florida, 32952, United States|Pfizer Investigational Site, Titusville, Florida, 32796, United States|Pfizer Investigational Site, Creve Coeur, Missouri, 63141, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110-1094, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110, United States|Pfizer Investigational Site, St. Peters, Missouri, 63376, United States|Pfizer Investigational Site, Basking Ridge, New Jersey, 07920, United States|Pfizer Investigational Site, Commack, New York, 11725, United States|Pfizer Investigational Site, New York, New York, 10022, United States|Pfizer Investigational Site, Sayre, Pennsylvania, 18840, United States|Pfizer Investigational Site, Austin, Texas, 78705, United States|Pfizer Investigational Site, Austin, Texas, 78745, United States|Pfizer Investigational Site, Austin, Texas, 78758, United States|Pfizer Investigational Site, Austin, Texas, 78759, United States|Pfizer Investigational Site, Round Rock, Texas, 78664, United States|Pfizer Investigational Site, Pessac, Be1 04495, 33604, France|Pfizer Investigational Site, Marseille Cedex 09, 13009, France|Pfizer Investigational Site, Saint-Priest en Jarez Cedex, 42271, France|Pfizer Investigational Site, Toulouse cedex 9, 31059, France|Pfizer Investigational Site, Bologna, 40139, Italy|Pfizer Investigational Site, Genova, 16132, Italy|Pfizer Investigational Site, Orbassano (TO), 10043, Italy|Pfizer Investigational Site, Roma, 00151, Italy|Pfizer Investigational Site, Madrid, 28046, Spain|Pfizer Investigational Site, Valencia, 46014, Spain Less << |
NCT00981890 | Brain Metastases | PHASE1 | COMPLETED | 2025-05-22 | University Health Network, Pri... More >>ncess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada Less << |
NCT01121562 | Pancreatic Neuroendocrine Tumo... More >>rs Less << | PHASE2 | COMPLETED | 2025-11-13 | Aichi Cancer Center Central Ho... More >>spital, Nagoya, Aichi, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, Japan|Kyushu University Hospital, Fukuoka, Japan|Osaka Police Hospital, Osaka, Japan Less << |
NCT00299741 | Prostate Cancer | PHASE2 | COMPLETED | 2025-06-08 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Beth Israel-Deaconess Medical Center, Boston, Massachusetts, 02115, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less << |
NCT06032728 | Renal Cell Carcinoma | NOT_YET_RECRUITING | 2033-10-01 | - | |
NCT01069770 | Clear Cell Renal Cell Carcinom... More >>a|Metastasis Less << | PHASE2 | UNKNOWN | 2025-06-12 | National Cancer Center, Goyang... More >>-si, Gyeonggi-do, 410-769, Korea, Republic of|Chungbuk University Hospital, Cheonju, 361-711, Korea, Republic of|Samsung Medical Center, Seoul, 137-710, Korea, Republic of Less << |
NCT03140176 | Metastatic Renal Cell Carcinom... More >>a Less << | TERMINATED | 2022-01-22 | Pierre Et Marie Curie Center, ... More >>Algers, 16005, Algeria|CAC Annaba, Annaba, Algeria|Hanene Djedi, Annaba, Algeria|Kasr Al Aini, Cairo, 11562, Egypt|National Cancer Institute, Cairo, 11796, Egypt|Demerdash Hospital, Cairo, Egypt|Kuwait Cancer Control Center, Kuwait City, 70653, Kuwait|Institut National D'Oncologie, Rabat, Morocco Less << | |
NCT00864864 | Glioblastoma|Brain Tumor | EARLY_PHASE1 | COMPLETED | 2025-05-13 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less << |
NCT01829217 | Lung Cancer | PHASE2 | COMPLETED | 2025-01-18 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02214, United States|Beth Isreal Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less << |
NCT00577382 | Mucosal Lentiginous Melanoma|A... More >>cral Lentiginous Malignant Melanoma Less << | PHASE2 | COMPLETED | 2025-08-14 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Washington University in St. Louis, St. Louis, Missouri, 63110, United States|Vanderbilt University, Nashville, Tennessee, 37212, United States Less << |
NCT02848768 | Metastatic Clear Cell Renal Ce... More >>ll Carcinoma Less << | COMPLETED | - | CHU de Rennes, Rennes, 35033, ... More >>France Less << | |
NCT02071641 | Metastatic Renal Cell Carcinom... More >>a Less << | PHASE2 | TERMINATED | 2025-09-16 | VU Medical Center, Amsterdam, ... More >>1081 HV, Netherlands Less << |
NCT01082809 | Advanced Biliary Tract Adenoca... More >>rcinoma Less << | PHASE2 | COMPLETED | 2025-02-12 | Samsung Medical Center, Seoul,... More >> Korea, Republic of Less << |
NCT00859456 | Sarcoma, Soft Tissue | PHASE2 | TERMINATED | 2025-02-13 | Columbia University Medical Ce... More >>nter, New York, New York, 10032, United States Less << |
NCT00056693 | Neuroendocrine Tumors | PHASE2 | COMPLETED | 2025-09-06 | Pfizer Investigational Site, B... More >>irmingham, Alabama, 35233, United States|Pfizer Investigational Site, Birmingham, Alabama, 35294, United States|Pfizer Investigational Site, Los Angeles, California, 90033-0800, United States|Pfizer Investigational Site, Los Angeles, California, 90033, United States|Pfizer Investigational Site, San Francisco, California, 94115-1705, United States|Pfizer Investigational Site, Pinckneyville, Illinois, 62274, United States|Pfizer Investigational Site, Boston, Massachusetts, 02114, United States|Pfizer Investigational Site, Boston, Massachusetts, 02115, United States|Pfizer Investigational Site, Boston, Massachusetts, 02215, United States|Pfizer Investigational Site, St Louis, Missouri, 63110, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19111, United States Less << |
NCT03592199 | Clear Cell Renal Cell Carcinom... More >>a Less << | PHASE2 | UNKNOWN | 2022-12-11 | Instituto do Cancer do Estado ... More >>de S?o Paulo, S?o Paulo, 01246000, Brazil Less << |
NCT01718327 | Unresectable and Advanced Chol... More >>angiocarcinoma Less << | PHASE2 | COMPLETED | 2016-11-17 | H?pital Beaujon, Clichy, 92118... More >>, France|H?pital privé Jean Mermoz, Lyon, 69008, France|CHU La Timone, Marseille, 13005, France|H?pital Saint Antoine, Paris, 75012, France|Institut Mutualiste Montsouris, Paris, 75014, France|Institut Gustave Roussy, Villejuif, 94805, France Less << |
NCT02623127 | Thymic Carcinoma | PHASE2 | COMPLETED | 2025-10-18 | Seoul National University Bund... More >>ang Hospital, Seongnam, 463-707, Korea, Republic of Less << |
NCT04076787 | Metastatic Renal Cell Carcinom... More >>a Less << | COMPLETED | 2018-09-02 | University of Calgary, Calgary... More >>, Alberta, P2N4N2, Canada Less << | |
NCT01286896 | Malignant Solid Tumour | PHASE1 | UNKNOWN | 2025-12-11 | The Netherlands Cancer Institu... More >>te - Antoni van Leeuwenhoek Hospital, Amsterdam, 1066CX, Netherlands Less << |
NCT00694096 | Renal Cell Cancer | PHASE1 | COMPLETED | 2025-09-14 | Huntsman Cancer Institute, Sal... More >>t Lake City, Utah, 84112, United States Less << |
NCT01498835 | Soft Tissue Sarcoma | PHASE1 | COMPLETED | 2025-02-15 | Helios Klinikum Bad Saarow, Ba... More >>d Saarow, 15526, Germany|University Medical Center Mannheim, Mannheim, 68167, Germany Less << |
NCT00535379 | Glioblastoma Multiforme | PHASE2 | UNKNOWN | 2025-01-11 | LKH Feldkirch, Feldkirch, Aust... More >>ria|Medical University Innsbruck, Innsbruck, 6020, Austria|LNK Wagner-Jauregg, Linz, Austria|Paracelsus Medical University, Salzburg, 5020, Austria|Medical University Vienna, Vienna, Austria|Kaiser-Franz-Josef Spital Wien, Wien, Austria|University Hospital of Heidelberg, Heidelberg, Baden-Württemberg, 69120, Germany|University Hospital of Mannheim, Mannheim, Baden-Württemberg, 68167, Germany|University Hospital of Bonn, Bonn, Nordrhein-Westfalen, 53105, Germany|University Hospital of Berlin, Berlin, 13353, Germany Less << |
NCT03519542 | Metastatic Renal Cell Carcinom... More >>a Less << | COMPLETED | 2025-07-18 | Hospital Clínico Universitario... More >> de Santiago de Compostela, Santiago de Compostela, A Coru?a, 15706, Spain|Hospital Universitario central de Asturias, Oviedo, Asturias, 33011, Spain|Hospital Marqués de Valdecilla, Santander, Cantabria, 39008, Spain|Hospital Universitarios de Burgos, Burgos, 09006, Spain|Hospital Universiario de León, León, 24080, Spain|Hospital Gregorio Mara?ón, Madrid, 28007, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28024, Spain|Hospital Clínico (Madrid), Madrid, 28040, Spain|Hospital 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Carlos Haya, Málaga, 29010, Spain|Hospital Clínico Lozano Blesa, Zaragoza, 50009, Spain Less << | |
NCT00798889 | Solid Tumors | COMPLETED | 2025-12-11 | Pfizer Investigational Site, B... More >>irmingham, Alabama, 35233-2115, United States|Pfizer Investigational Site, Birmingham, Alabama, 35233, United States|Pfizer Investigational Site, Birmingham, Alabama, 35294, United States|Pfizer Investigational Site, Los Angeles, California, 90033, United States|Pfizer Investigational Site, Los Angeles, California, 90095, United States|Pfizer Investigational Site, San Francisco, California, 94115-1705, United States|Pfizer Investigational Site, San Francisco, California, 94115, United States|Pfizer Investigational Site, Santa Monica,, California, 90404, United States|Pfizer Investigational Site, Aurora, Colorado, 80045, United States|Pfizer Investigational Site, Indianapolis, Indiana, 46202, United States|Pfizer Investigational Site, Boston, Massachusetts, 02114, United States|Pfizer Investigational Site, Boston, Massachusetts, 02115, United States|Pfizer Investigational Site, Boston, Massachusetts, 02215, United States|Pfizer Investigational Site, Ann Arbor, Michigan, 48109-0843, United States|Pfizer Investigational Site, Detroit, Michigan, 48201, United States|Pfizer Investigational Site, Farmington Hills, Michigan, 48334, United States|Pfizer Investigational Site, Minneapolis, Minnesota, 55455-0392, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87131-0001, United States|Pfizer Investigational Site, Albuqurque, New Mexico, 87106, United States|Pfizer Investigational Site, New York, New York, 10021, United States|Pfizer Investigational Site, New York, New York, 10022, United States|Pfizer Investigational Site, New York, New York, 10032, United States|Pfizer Investigational Site, Durham, North Carolina, 27710, United States|Pfizer Investigational Site, Cleveland, Ohio, 44195, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19111, United States|Pfizer Investigational Site, Myrtle Beach, South Carolina, 29572, United States|Pfizer Investigational Site, Franklin, Tennessee, 37067, United States|Pfizer Investigational Site, Gallatin, Tennessee, 37066, United States|Pfizer Investigational Site, Hermitage, Tennessee, 37076, United States|Pfizer Investigational Site, Lebanon, Tennessee, 37087, United States|Pfizer Investigational Site, Murfreesboro, Tennessee, 37130, United States|Pfizer Investigational Site, Nashville, Tennessee, 37203, United States|Pfizer Investigational Site, Nashville, Tennessee, 37205, United States|Pfizer Investigational Site, Nashville, Tennessee, 37207, United States|Pfizer Investigational Site, Nashville, Tennessee, 37211, United States|Pfizer Investigational Site, Nashville, Tennessee, 37212, United States|Pfizer Investigational Site, Nashville, Tennessee, 37232, United States|Pfizer Investigational Site, Smyrna, Tennessee, 37167, United States|Pfizer Investigational Site, Dallas, Texas, 75246, United States|Pfizer Investigational Site, Houston, Texas, 77030-4009, United States|Pfizer Investigational Site, Madison, Wisconsin, 53792, United States|Pfizer Investigational Site, Randwick, New South Wales, 2031, Australia|Pfizer Investigational Site, East Melbourne, Victoria, 3002, Australia|Pfizer Investigational Site, Heidelberg, Victoria, 3084, Australia|Pfizer Investigational Site, Montreal, Quebec, H2L 4M1, Canada|Pfizer Investigational Site, Villejuif Cedex, 94805, France|Pfizer Investigational Site, Thessaloniki, 564 03, Greece|Pfizer Investigational Site, Milano, 20133, Italy|Pfizer Investigational Site, Milano, 20141, Italy|Pfizer Investigational Site, Nijmegen, Gld, 6525 GA, Netherlands|Pfizer Investigational Site, Singapore, 308433, Singapore|Pfizer Investigational Site, Lund, Sweden|Pfizer Investigational Site, Stockholm, Sweden|Pfizer Investigational Site, St. Gallen, CH-9007, Switzerland|Pfizer Investigational Site, Leeds, LS9 7TF, United Kingdom|Pfizer Investigational Site, London, NW1 2PG, United Kingdom|Pfizer Investigational Site, London, SW3 6JJ, United Kingdom|Pfizer Investigational Site, Newcastle-Upon-Tyne, NE4 6BE, United Kingdom Less << | |
NCT00589784 | CNS Cancer|Meningioma|Intracra... More >>nial Hemangiopericytoma|Hemangioblastoma|Neurofibromatosis Less << | PHASE2 | COMPLETED | 2025-10-14 | Dana Farber Cancer Institute, ... More >>Boston, Massachusetts, 02115, United States|Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States|Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, 11725, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|University of Pittsburgh Medical Center, Pittsburg, Pennsylvania, United States|University of Virginia Health Science Center, Charlottesville, Virginia, 22908, United States Less << |
NCT01216657 | Chemo-refractory Melanoma | PHASE2 | TERMINATED | 2025-05-13 | Krankenhaus Nordwest, Frankfur... More >>t/Main, 60488, Germany Less << |
NCT00089648 | Carcinoma, Renal Cell | PHASE2 | COMPLETED | 2025-03-08 | Pfizer Investigational Site, D... More >>uarte, California, 91010, United States|Pfizer Investigational Site, Pasadena, California, 91105, United States|Pfizer Investigational Site, San Francisco, California, 94115, United States|Pfizer Investigational Site, Chicago, Illinois, 60637-1460, United States|Pfizer Investigational Site, Boston, Massachusetts, 02114, United States|Pfizer Investigational Site, Boston, Massachusetts, 02115, United States|Pfizer Investigational Site, Boston, Massachusetts, 02215, United States|Pfizer Investigational Site, Durham, North Carolina, 27710, United States|Pfizer Investigational Site, Cleveland, Ohio, 44195, United States|Pfizer Investigational Site, Nashville, Tennessee, 37232-5536, United States|Pfizer Investigational Site, Dallas, Texas, 75246, United States Less << |
NCT01824615 | Ovarian Cancer|Adverse Effects | PHASE2 | COMPLETED | 2025-01-16 | Cathay General Hospital, Taipe... More >>i, 106, Taiwan Less << |
NCT00843037 | Paraganglioma|Pheochromocytoma | PHASE2 | COMPLETED | 2022-03-14 | Tom Baker Cancer Centre, Calga... More >>ry, Alberta, T2N 4N2, Canada|University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|H?pital Notre-Dame du CHUM, Montreal, Quebec, H2L 4M1, Canada|University Medical Centre Groningen, Groningen, Netherlands Less << |
NCT00599313 | Metastatic Prostate Cancer | PHASE2 | COMPLETED | 2025-06-09 | Hematology Oncology Associates... More >>, Phoenix, Arizona, 85012, United States|Connecticut Oncology & Hematology, LLP, Torrington, Connecticut, 06790, United States|Ocala Oncology Center, Ocala, Florida, 34474, United States|Cancer Care & Hematology Specialista of Chicagoland, Niles, Illinois, 60714, United States|Hope Center, Terre Haute, Indiana, 47802, United States|Maryland Oncology Hematology, P.A., Columbia, Maryland, 21044, United States|Alliance Hematology Oncology PA, Westminster, Maryland, 21157, United States|Missouri Cancer Associates, Columbia, Missouri, 65201, United States|St. Joseph Oncology, Inc., Saint Joseph, Missouri, 64507, United States|Arch Medical Services, Inc. DBA The Cntr for Cancer Care & Research, Saint Louis, Missouri, 63141, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|NH Oncology-Hematology PA, Hooksett, New Hampshire, 03106, United States|New Mexico Cancer Care Associates, Santa Fe, New Mexico, 87505, United States|New York Oncology Hematology, P.C., Albany, New York, 12206, United States|Interlakes Oncology Hematology, PC, Rochester, New York, 14623, United States|Cancer Centers of North Carolina, Raleigh, North Carolina, 27607, United States|Greater Dayton Cancer Center, Kettering, Ohio, 45409, United States|Medical Oncology Associates, Kingston, Pennsylvania, 18704, United States|Cancer Centers of the Carolinas, Greenville, South Carolina, 29605, United States|Texas Cancer Center-Abilene(South), Abilene, Texas, 79606, United States|Texas Oncology, P.A.-Amarillo, Amarillo, Texas, 79106, United States|Texas Cancer Center, Arlington, Texas, 76014, United States|Texas Oncology Cancer Center, Austin, Texas, 78731, United States|Mamie McFaddin Ward Cancer Center, Beaumont, Texas, 77702, United States|Texas Oncology, P.A.-Bedford, Bedford, Texas, 76022, United States|Texas Cancer Center at Medical City, Dallas, Texas, 75230, United States|Texas Onclogy, P.A., Dallas, Texas, 75231, United States|Methodist Charlton Cancer Ctr., Dallas, Texas, 75237, United States|Texas Oncology, P.A., Dallas, Texas, 75246, United States|Texas Cancer Center, Denton, Texas, 76210, United States|El Paso Cancer Treatment Ctr, El Paso, Texas, 79915, United States|Texas Oncology, P.A., Fort Worth, Texas, 76104, United States|Allison Cancer Center, Midland, Texas, 79701, United States|Texas Oncology-Odessa, Odessa, Texas, 79761, United States|Paris Regional Cancer Center, Paris, Texas, 75460, United States|HOAST-Medical Dr., San Antonio, Texas, 78229, United States|Texas Oncology Cancer Center-Sugar Land, Sugar Land, Texas, 77479, United States|Texas Oncology Cancer Care and Research, Waco, Texas, 76712, United States|Texas Oncology, P.A., Webster, Texas, 77598, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States|Onc and Hem Associates of SW VA, Inc., Salem, Virginia, 24153, United States|Puget Sound Cancer Center-Edmonds, Edmonds, Washington, 98026, United States|Puget Sound Cancer Center-Seattle, Seattle, Washington, 98133, United States|Northwest Cancer Specialists-Vancouver, Vancouver, Washington, 98684, United States|Yakima Valley Mem Hosp/North Star Lodge, Yakima, Washington, 98902, United States Less << |
NCT01499121 | Clear Cell, Metastatic Renal C... More >>ell Carcinoma Less << | PHASE2 | COMPLETED | 2017-09-30 | Tom Baker Cancer Centre, Calga... More >>ry, Alberta, T2N 4N2, Canada|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|BC Cancer Agency - Vancouver, Vancouver, British Columbia, V5Z 4E6, Canada|CancerCare Manitoba, Winnipeg, Manitoba, R3E 0V9, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, B3H 3A7, Canada|Juravinski Cancer Centre, Hamilton, Ontario, L8V 5C2, Canada|Kingston General Hospital Research Institute, Kingston, Ontario, K7L 2V7, Canada|London Health Sciences Centre, London, Ontario, N6A 4L6, Canada|Durham Regional Cancer Centre, Oshawa, Ontario, L1G 2B9, Canada|Ottawa Hospital Cancer Centre, Ottawa, Ontario, K1H 8L6, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada|Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada|Notre-Dame Hospital, Montreal, Quebec, H2W 1T8, Canada Less << |
NCT00663559 | Carcinoma Renal Cells | PHASE2 | COMPLETED | 2025-02-10 | Hospital Central de Asturias, ... More >>Oviedo, Asturias, 33006, Spain|Hospital Parc Taulí, Sabadell, Barcelona, 08208, Spain|Hospital CLINIC, Barcelona, 08036, Spain|Hospital Reina Sofía, Córdoba, 14004, Spain|Hospital de Jaén, Jaén, 23007, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital lozano Blesa, Zaragoza, 50009, Spain Less << |
NCT01033981 | Metastatic Renal Cell Carcinom... More >>a Less << | TERMINATED | 2025-02-11 | Pfizer Investigational Site, P... More >>anama City, Panama Less << | |
NCT01168440 | Von Hippel-Lindau Disease | PHASE2 | COMPLETED | 2025-02-11 | Hospital Saint André - Service... More >> de cancérologie, Bordeaux, 33075, France|Hopital Kremlin-Bicêtre, Kremlin-Bicêtre, 94275, France|H?pital Européen Georges Pompidou - Service d'Oncologie Médicale, Paris, 75015, France Less << |
NCT00768144 | Ovarian Cancer|Fallopian Tube ... More >>Cancer|Peritoneal Cancer Less << | PHASE2 | COMPLETED | 2025-02-13 | Dana-Farber Cancer Institute, ... More >>Boston, Massachusetts, 02115, United States|Massachusetts General Hospital, Boston, Massachusetts, 02214, United States|Beth-Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States Less << |
NCT00510640 | Cancer|Thyroid Carcinoma | PHASE2 | COMPLETED | 2025-03-12 | Centre Paul Papin - 2 rue Moll... More >>, Angers, 49100, France|Département Endocrinolo-Diabéto-Nutrition - CHU d'Angers - 4 rue de Larray, Angers, 49933, France|Service d'Oncologie Médicale et de Radiothérapie - H?pital Saint André - 1 rue Jean Burguet, Bordeaux, 33075, France|Fédération Endocrinologie - Groupe Hospitalier Est - H?pital neurologique - CHU Lyon - 59 Boulevard Pinel, Bron, 69677, France|Service d'Endocrinologie et maladies métaboliques, Clinique Marc Linquette - rue du Pr Laguesse, Lille, 59037, France|Centre Léon Bérard - Département de Médecine - 28 rue Laennec, Lyon, 69373, France|Service d'Endocrinologie, CHU Timone, AP-HM - 254 rue St Pierre, Marseille, 13385, France|Service des Maladies Endocriniennes - H?pital Lapeyronie - 191 avenue du Doyen Gaston Giraud, Montpellier, 34295, France|Centre Paul Lamarque - Va d'Aurelle - CRLC Val d'Aurelle - 208 rue des Apothicaires, Montpellier, 34298, France|Centre Antoine Lacassagne - 33 avenue de Valombrose, Nice, 06189, France|Service d'Endocrinologie - H?pital de l'Archet I - Route Saint Antoine de Jinestière, Nice, 06202, France|Service de Cancérologie Médicale - HEGP - 20 rue Leblanc, Paris, 75015, France|Service d'Oncologie Médicale, Institut Claudius Regaud - 20-24 rue du Pont Saint Pierre, Toulouse, 31052, France|Service d'endocrinologie et Maladies Métaboliques, Groupe Hospitalier Rangueil-Larrey CHU Toulouse - avenue Prof Jean Poulhes, Toulouse, 31059, France|Service d'Endocrinologie - CHU de Nancy, H?pital de Brabois - rue du Morvan, Vandoeuvre les Nancy, 54511, France Less << |
NCT02398552 | Metastatic Renal Cell Carcinom... More >>a Less << | PHASE2 | UNKNOWN | 2025-03-17 | Chinese acadamy of medical sci... More >>ence cancer institute & hospital, Beijing, Beijing, 100021, China|Peking University First Hospital, Beijing, Beijing, 100034, China|Beijing Cancer Hospital, Beijing, Beijing, 100142, China|Sun Yat-sen university cancer center, Guangzhou, Guangdong, 510060, China|Cancer Hospital, Fudan University, Shanghai, Shanghai, 200032, China|Tianjin medical university cancer institute & hospital, Tianjin, Tianjin, 300060, China Less << |
NCT03066427 | Clear Cell Renal Carcinoma | PHASE2 | COMPLETED | 2020-09-22 | ICO Duran i Reynals, L'Hospita... More >>let de Llobregat, Barcelona, 08908, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clínic i Provincial de Barcelona, Barcelona, 08036, Spain|Complejo Hospitalario Regional Reina Sofía, Córdoba, 14004, Spain|Hospital Ramón Y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Centro Integral Oncologico Clara Campal, Madrid, Spain|MD Anderson Cancer Center Madrid, Madrid, Spain|Hospital Central de Asturias, Oviedo, Spain Less << |
NCT01219751 | Metastatic Renal Cell Carcinom... More >>a Less << | PHASE2 | UNKNOWN | 2025-09-11 | Asan Medical Center, Seoul, 13... More >>8-736, Korea, Republic of Less << |
NCT04115189 | Metastatic Renal Cell Carcinom... More >>a ( mRCC) Less << | COMPLETED | 2020-12-02 | Instituto Médico Especializado... More >> Alexander Fleming, Buenos Aires, Argentina|Sanatorio del Salvador - Cordoba, Cordoba, Argentina|Centro Oncológico de Integración Regional in Mendoza, Mendoza, M5500AYB, Argentina|Escola Paulista de Medicina - UNIFESP, S?o Paulo, Brazil|Fundacion Cardiovascular de Colombia, Bogotá, Colombia|Sociedad de Oncologia y Hematologia Del Cesar ltda (SOHEC), Valledupar, Colombia|Hospital Eugenio Espejo, Quito, Ecuador Less << | |
NCT00794950 | Urinary Tract Urothelial Carci... More >>noma Less << | PHASE2 | COMPLETED | 2016-08-22 | Mark P. Schoenberg, MD, Baltim... More >>ore, Maryland, 21287-2101, United States|Alon Weizer, MD, Ann Arbor, Michigan, 48109, United States Less << |
NCT05745142 | Carcinoma, Renal Cell|Clear-ce... More >>ll Metastatic Renal Cell Carcinoma Less << | COMPLETED | 2023-02-23 | Pfizer, Istanbul, 34394, Turke... More >>y Less << | |
NCT02058901 | Solid Tumors | PHASE1 | COMPLETED | 2025-06-19 | VU University Medical Center, ... More >>Amsterdam, 1081HV, Netherlands Less << |
NCT02691793 | Refractory Solid Tumors | PHASE4 | COMPLETED | 2019-11-19 | Samsung Medical Center, Seoul,... More >> Seoul, Korea, Republic Of, 135-710, Korea, Republic of Less << |
NCT00783653 | Acute Myeloid Leukemia | PHASE1|PHASE2 | COMPLETED | - | Prof. Dr. med. Walter Fiedler,... More >> Hamburg, 20246, Germany|PD Dr. med. Jürgen Krauter, Hannover, 30625, Germany|Dr. Katharina G?tze, München, 81675, Germany|Prof. Dr. Helmut R. Salih, Tübingen, 72076, Germany|Dr. Richard Schlenk, Ulm, 89081, Germany Less << |
NCT02689167 | Kidney Neoplasms|Metastatic Re... More >>nal Cell Cancer Less << | PHASE2 | UNKNOWN | 2025-02-24 | CHU Besancon, Besancon, Franch... More >>e-Comté, 25030, France Less << |
NCT04368546 | Renal Cell Cancer Metastatic|H... More >>ypertension|Sodium Imbalance Less << | COMPLETED | 2020-03-01 | Experimental and Clinical Rese... More >>arch Center, Clinical Research Unit, Berlin, 13125, Germany Less << | |
NCT00796861 | Ascites | PHASE2 | TERMINATED | 2025-04-11 | Penn State Milton S. Hershey M... More >>edical Center, Hershey, Pennsylvania, 17033, United States Less << |
NCT02713763 | Pancreatic Neuroendocrine Tumo... More >>ur Metastatic Less << | PHASE2 | COMPLETED | 2019-10-23 | Hospital Universitario Central... More >> de Asturias, Oviedo, Asturias, 33011, Spain|Hospital Universitario Valle de Hebrón, Barcelona, 08035, Spain|Hospital Reina Sofía, Córdoba, 14004, Spain|Hospital Universitario Donostia, Donostia/San Sebastián, 20014, Spain|Hospital Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital General Universitario J.M. Morales Meseguer, Murcia, 30008, Spain|Complejo Hospitalario Regional Virgen Del Rocío, Sevilla, 41013, Spain|Instituto Valenciano de Oncología, Valencia, 46009, Spain Less << |
NCT03449173 | Type B3 Thymoma|Thymic Carcino... More >>ma Less << | PHASE2 | UNKNOWN | 2022-05-31 | National Cancer Institute, Mil... More >>an, 20133, Italy Less << |
NCT00453895 | Adrenocortical Carcinoma | PHASE2 | COMPLETED | 2025-02-12 | Charite Berlin, Berlin, German... More >>y|Dept. of Medicine I, University of Wuerzburg, Wuerzburg, 97080, Germany Less << |
NCT00092001 | Carcinoma, Non-Small-Cell Lung | PHASE2 | COMPLETED | 2025-03-07 | Pfizer Investigational Site, B... More >>altimore, Maryland, 21231-1000, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110-1094, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110, United States|Pfizer Investigational Site, St. Peters, Missouri, 63376, United States|Pfizer Investigational Site, Chapel Hill, North Carolina, 27599-7600, United States|Pfizer Investigational Site, Clinton, North Carolina, 28382, United States|Pfizer Investigational Site, Goldsboro, North Carolina, 27534, United States|Pfizer Investigational Site, Pollocksville, North Carolina, 28573, United States|Pfizer Investigational Site, Wilson, North Carolina, 27893, United States|Pfizer Investigational Site, Pittsburgh, Pennsylvania, 15232, United States|Pfizer Investigational Site, Charlottesville, Virginia, 22908, United States|Pfizer Investigational Site, Orbassano (Torino), 10043, Italy|Pfizer Investigational Site, Badalona, Barcelona, 08916, Spain|Pfizer Investigational Site, Barcelona, 08025, Spain Less << |
NCT01042795 | Urothelial Carcinoma|Bladder C... More >>ancer Less << | PHASE2 | TERMINATED | 2025-01-13 | University of Michigan, Ann Ar... More >>bor, Michigan, 48109, United States Less << |
NCT01034878 | Carcinoma, Renal Cell | PHASE2 | COMPLETED | 2025-12-14 | Istituto Clinco Humanitas, Roz... More >>zano, Milano, 20089, Italy Less << |
NCT00226811 | Stomach Neoplasms | PHASE2 | COMPLETED | 2025-05-08 | Pfizer Investigational Site, N... More >>anjing, Jiangsu, 210002, China|Pfizer Investigational Site, Beijing, 100036, China|Pfizer Investigational Site, Beijing, China|Pfizer Investigational Site, Guangzhou, 510515, China|Pfizer Investigational Site, Hong Kong, Hong Kong|Pfizer Investigational Site, Shatin, Hong Kong|Pfizer Investigational Site, Ancona, 60020, Italy|Pfizer Investigational Site, Genova, 16132, Italy|Pfizer Investigational Site, Kashiwa, Chiba, Japan|Pfizer Investigational Site, Suntougun, Shizuoka, Japan|Pfizer Investigational Site, Chuo-ku, Tokyo, Japan|Pfizer Investigational Site, Seoul, 110-744, Korea, Republic of|Pfizer Investigational Site, Seoul, 120-752, Korea, Republic of|Pfizer Investigational Site, Seoul, 135-710, Korea, Republic of|Pfizer Investigational Site, Seoul, 138-736, Korea, Republic of|Pfizer Investigational Site, Porto, 4200-072, Portugal|Pfizer Investigational Site, Kwei-Shan, Taoyuan, 333, Taiwan|Pfizer Investigational Site, Taipei, 100, Taiwan Less << |
NCT00886132 | Adenoid Cystic Carcinoma|Saliv... More >>ary Gland Cancer Less << | PHASE2 | COMPLETED | 2025-12-12 | Princess Margaret Hospital, To... More >>ronto, Ontario, M5G 2M9, Canada Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.51mL 0.50mL 0.25mL |
12.55mL 2.51mL 1.25mL |
25.10mL 5.02mL 2.51mL |